266 related articles for article (PubMed ID: 22001556)
1. Development and validation of a cell-based SEAP reporter assay for the detection of neutralizing antibodies against an anti-IL-13 therapeutic antibody.
Liao K; Sikkema D; Wang C; Chen K; DeWall S; Lee TN
J Immunol Methods; 2012 Jan; 375(1-2):258-63. PubMed ID: 22001556
[TBL] [Abstract][Full Text] [Related]
2. Development and optimization of a cell-based neutralizing antibody assay using a sample pre-treatment step to eliminate serum interference.
McCutcheon KM; Quarmby V; Song A
J Immunol Methods; 2010 Jun; 358(1-2):35-45. PubMed ID: 20361968
[TBL] [Abstract][Full Text] [Related]
3. Development of an enzymatic assay for the detection of neutralizing antibodies against therapeutic angiotensin-converting enzyme 2 (ACE2).
Liao K; Sikkema D; Wang C; Lee TN
J Immunol Methods; 2013 Mar; 389(1-2):52-60. PubMed ID: 23298658
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a cell-based bioassay for the detection of neutralizing antibodies against recombinant human erythropoietin in clinical studies.
Wei X; Swanson SJ; Gupta S
J Immunol Methods; 2004 Oct; 293(1-2):115-26. PubMed ID: 15541282
[TBL] [Abstract][Full Text] [Related]
6. Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system.
St Ledger K; Agee SJ; Kasaian MT; Forlow SB; Durn BL; Minyard J; Lu QA; Todd J; Vesterqvist O; Burczynski ME
J Immunol Methods; 2009 Oct; 350(1-2):161-70. PubMed ID: 19732777
[TBL] [Abstract][Full Text] [Related]
7. Implementation of design of experiments (DOE) in the development and validation of a cell-based bioassay for the detection of anti-drug neutralizing antibodies in human serum.
Chen XC; Zhou L; Gupta S; Civoli F
J Immunol Methods; 2012 Feb; 376(1-2):32-45. PubMed ID: 22119514
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a pre-treatment procedure to eliminate human monoclonal antibody therapeutic drug and matrix interference in cell-based functional neutralizing antibody assays.
Xu W; Jiang H; Titsch C; Haulenbeek JR; Pillutla RC; Aubry AF; DeSilva BS; Arnold ME; Zeng J; Dodge RW
J Immunol Methods; 2015 Jan; 416():94-104. PubMed ID: 25445325
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
Stubenrauch K; Wessels U; Lenz H
J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
[TBL] [Abstract][Full Text] [Related]
10. Identification and elimination of target-related matrix interference in a neutralizing anti-drug antibody assay.
Schwickart M; Mehrzai F; Pearson J; Shaghasi N; Chavez C; Schneider A; Wu S; Roskos L; Liang M
J Immunol Methods; 2014 Jan; 403(1-2):52-61. PubMed ID: 24287421
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Quasi-Quantitative Bioassay for Neutralizing Antibodies Against CP-870,893.
Baltrukonis DJ; Finco-Kent D; Kawabata TT; Poirier M; Lesauteur L
J Immunotoxicol; 2006 Sep; 3(3):157-64. PubMed ID: 18958696
[TBL] [Abstract][Full Text] [Related]
12. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
[TBL] [Abstract][Full Text] [Related]
13. Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparison.
Barger TE; Kuck AJ; Chirmule N; Swanson SJ; Mytych DT
Nephrol Dial Transplant; 2012 Feb; 27(2):688-93. PubMed ID: 21602184
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta.
Hermanrud C; Ryner M; Luft T; Jensen PE; Ingenhoven K; Rat D; Deisenhammer F; Sørensen PS; Pallardy M; Sikkema D; Bertotti E; Kramer D; Creeke P; Fogdell-Hahn A;
J Immunol Methods; 2016 Mar; 430():1-9. PubMed ID: 26779831
[TBL] [Abstract][Full Text] [Related]
15. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
Qiu ZJ; Ying Y; Fox M; Peng K; Lewin-Koh SC; Coleman D; Good J; Lowe J; Rahman A; Yang J; Jiang J; Quarmby V; Song A
J Immunol Methods; 2010 Oct; 362(1-2):101-11. PubMed ID: 20868690
[TBL] [Abstract][Full Text] [Related]
16. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
[TBL] [Abstract][Full Text] [Related]
17. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.
Li J; Schantz A; Schwegler M; Shankar G
J Pharm Biomed Anal; 2011 Jan; 54(2):286-94. PubMed ID: 20869832
[TBL] [Abstract][Full Text] [Related]
18. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.
Tornetta M; Fisher D; O'Neil K; Geng D; Schantz A; Brigham-Burke M; Lombardo D; Fink D; Knight D; Sweet R; Tsui P
J Immunol Methods; 2007 Dec; 328(1-2):34-44. PubMed ID: 17888945
[TBL] [Abstract][Full Text] [Related]
19. A Neutralizing Antibody Assay Based on a Reporter of Antibody-Dependent Cell-Mediated Cytotoxicity.
Wu Y; Li JJ; Kim HJ; Liu X; Liu W; Akhgar A; Bowen MA; Spitz S; Jiang XR; Roskos LK; White WI
AAPS J; 2015 Nov; 17(6):1417-26. PubMed ID: 26205082
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins.
Hu J; Wala I; Han H; Nagatani J; Barger T; Civoli F; Kaliyaperumal A; Zhuang Y; Gupta S
J Immunol Methods; 2015 Apr; 419():1-8. PubMed ID: 25795420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]